CAS: 948570-30-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Rontalizumab REF: TM-T81259CAS: 948570-30-7 | >95% | 416,00 €~2.848,00 € | Mar 28 Ene 25 |
 | Rontalizumab REF: 3D-CLA1244CAS: 948570-30-7 | - - - | A consultar | Lun 03 Feb 25 |
Rontalizumab
CAS:948570-30-7
Rontalizumab, a humanized IgG1 monoclonal antibody, targets IFN-α and is utilized in research on systemic …
Pureza:
>95%
Forma y color:
Liquid
Ref: TM-T81259
| 1mg | 416,00 € | ||
| 5mg | 776,00 € | ||
| 10mg | 1.060,00 € | ||
| 25mg | 1.604,00 € | ||
| 50mg | 2.158,00 € | ||
| 100mg | 2.848,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Enero de 2025
Rontalizumab
CAS:948570-30-7
Anti-IFN-α Humanized monoclonal antibody; potential treatment of systemic lupus erythematosus
Ref: 3D-CLA1244
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 3 de Febrero de 2025
